Table 2.
Reclassification of SNP allele calls by use of polar transformation compared to conventional methods
Genotype | Dhfr Locus 59 | Chr1SNP | Chr7SNP | Chr8SNP | Chr9SNP | Chr13SNP | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Status | XYa | Polarb | XYa | Polarb | XYa | Polarb | XYa | Polarb | XYa | Polarb | XYa | Polarb |
Not Infected | 127 | 137 | 77 | 104 | 92 | 92 | 70 | 28 | 66 | 95 | 92 | 93 |
Inf. w/Allele 1 | 25c | 63 | 19 | 28 | 48 | 60 | 141 | 147 | 4 | 127 | 47 | 108 |
Inf. w/Allele 2 | 25d | 37 | 46 | 166 | 102 | 152 | 42 | 27 | 44 | 71 | 77 | 83 |
Mixed Infection | 87 | 17 | 215 | 24 | 115 | 28 | 41 | 34 | 243 | 36 | 141 | 41 |
Uncertaine | - | 10 | - | 35 | - | 25 | - | 58 | - | 28 | - | 32 |
Total Samplesf | 264 | 357 | 357 | 294 | 357 | 357 | ||||||
Reclassifiedg | 86 | 226 | 96 | 76 | 237 | 126 |
aCounts determined based on the conventional threshold of 3× standard deviations above the mean - see Figure 4A.
bCounts determined after applying polar transformation method - see Figure 4C.
cFor Dhfr locus 59, allele 1 is associated with drug sensitivity.
dFor Dhfr locus 59, allele 2 is associated with drug resistance.
eNo samples are considered uncertain by conventional (XY) methods, as confidence intervals are not considered.
fThe total number of samples genotyped at each locus.
gThe number of samples whose allele calls differed between the XY and polar transformation methods.